Allergy Treatment Market Size, Share, Growth | Analysis by 2028

report image

Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Allergy Type (Eye Allergies, Rhinitis, Asthma, Skin Allergies, Food Allergies, and Other Allergies) and Treatment (Anti-Allergy Drugs and Immunotherapies)

Publication Month: Mar 2021 | Report Code: TIPRE00004584 | No. of Pages: 191 | Category: Pharmaceuticals | Status: Published

The allergy treatment market is projected to reach US$ 35,812.33 million by 2028 from US$ 21,160.92 million in 2020; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028.

Allergies are hypersensitive responses by the human immune system to the substances that come in contact with the body. Some stimuli that cause an allergic reaction are dust mites, animal dander, cockroaches, pollens, mold, food substances, metals, elements, and more. Severe allergy can be life-threatening, which disturbs the normal functioning of organs, as asthma causes poor functioning of the lungs. The most effective treatment for allergy is to avoid the known allergens; there are medications such as steroids and antihistamines, and other therapies which prevent allergies. Allergy treatment is done primarily through drugs and long-term immunotherapies. The primary types of allergies studied in the market report are rhinitis, asthma, skin allergies, food allergies, eye allergies, and other allergies.

The allergy treatment market is segmented based on allergy type, treatment, and geography. The market, by geography, is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The market report offers insights and in-depth analysis of the market, emphasizing parameters such as market size, market trends, technological advancements in the market, and market dynamics, along with the global analysis of the competitive landscape of the leading market players that are driving the allergy treatment market growth.

The allergy treatment market growth is attributed to the increasing adoption of immunotherapy in allergy treatment and the developments in food allergy treatments which have significantly increased the market size and are expected to have a significant short-, mid-, and long-term impact on the  market size in the coming years. However, the lack of awareness about allergy treatments is hampering the growth of the market. The allergy treatment market report also studies the ongoing opportunities and market trends that can have a possible impact on the market growth.

Lucrative Regions for Allergy Treatment Market

Lucrative Regions for Allergy Treatment Market

Get more information on this report :

 

Market Insights

Developments in Food Allergy Treatments

Allergy is a common medical condition among a large share of the global population. It is one of the chronic health conditions that may result in severe consequences. Food allergies are ubiquitous in North America and Europe. The majority of people are allergic to garlic, wheat, peanuts, milk, fish, etc. According to estimations of the Center for Biologics Evaluation and Research of the Food and Drug Administration (FDA), ~1 million children in the US are allergic to peanuts, and one in five of these children is likely to surmount the respective allergy condition. In those who don’t outgrowth this allergy, the small intake of peanuts is unpredictable and harmful, which may result in severe reactions. Therefore, it becomes essential to develop treatment options for allergies to such common foodstuff.

Developments in the pharmaceuticals industry have enabled companies to offer treatment for peanut allergy reactions. In February 2020, the US FDA approved Palforzia, peanut (Arachis hypogaea) allergen powder-dnfp, as a treatment for peanut allergy, which is intended to alleviate allergic reactions such as anaphylaxis resulting from accidental peanut intake. The product is developed for children from the age group of 4–17. Palforzia was developed by Aimmune Therapeutics, Inc., a Nestle Health Science Company. It is administered in three dosages such as initial dose escalation, up-dosing, and maintenance. Palforzia is packaged in pull-apart color-coded capsules for dose escalation and up-dosing and in sachets for the maintenance stage. While administering, it is mixed with semi-solid food such as curd and pudding. It has been made available in the US, Canada, and Europe. Such developments in the food allergy treatment options and their effectiveness are the factors boosting the allergy treatment market growth.

Also, factors such as the increasing adoption of immunotherapy in allergy treatment through allergy shots and sublingual immunotherapy (SLIT) have shown to reduce allergic symptoms by 50–65% among the patients who have completed their dosages of allergens.

Allergy Type-Based Insights

The global allergy treatment market, based on allergy type, is divided into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. The rhinitis segment held the largest share of the market in 2020 and is anticipated to dominate the market during the forecast period and have a higher CAGR during the forecast period.

Allergy Treatment Market, by Allergy Type – 2020 and 2028

Allergy Treatment Market, by Allergy Type – 2020 and 2028

Get more information on this report :


Treatment-Based Insights

Based on the treatment, the allergy treatment market is bifurcated into anti-allergic drugs and immunotherapies. The anti-allergic drugs segment held a larger share of the market in 2020 and is expected to hold a significant share of the market during the forecast period. However, the immunotherapies segment is expected to witness a higher CAGR from 2021 to 2028.

Strategic Insights

Report Coverage - Allergy Treatment Market
Report CoverageDetails
Market Size Value inUS$ 21,160.92 million in 2020
Market Size Value byUS$ 35,812.33 million by 2028
Growth rateCAGR of 6.9% from 2021 to 2028.
Forecast Period2021-2028
Base Year2021
No. of Pages191
No. of Tables117
No. of Charts & Figures77
Historical data availableYes
Segments coveredAllergy Type and Treatment
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Various companies operating in the allergy treatment market adopt strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain the brand name, and meet the growing demand from end users.

Frequently Asked Questions

The allergies are the hypersensitive responses from human immune system to the substance that come in contact with body. Some factors which cause allergy are dust mite, animal dander, cockroach, pollens, mold, food substances, metals, elements, and more. The severe allergy can be life threatening which disturb the normal functioning of organs such as asthma caused poor functioning of lungs. The most effective treatment for allergy is to avoid the known allergens, while there are other therapy and medications such as steroids and antihistamines which prevent the allergies.
The factors that are driving growth of the market are increasing adoption of immunotherapy in allergy treatment and developments in food allergy treatments are anticipated to drive the growth of the global allergy treatment market during the forecast period. However, lack of awareness about allergy treatments are hindering the market growth.
The allergy treatment market majorly consists of the players such Johnson and Johnson Services, Inc.; Sanofi; AbbVie Inc. (Allergan plc); Pfizer Inc.; LETIPharma; ALK-Abelló A/S; Allergy Therapeutics; Stallergenes Greer; GlaxoSmithKline plc, and Dermapharm Holding are among others.

The List of Companies - Allergy Treatment Market

  1. Johnson and Johnson Services, Inc.
  2. Sanofi
  3. AbbVie Inc. (Allergan plc)
  4. Pfizer Inc.
  5. LETIPharma
  6. ALK-Abelló A/S
  7. Allergy Therapeutics
  8. Stallergenes Greer
  9. GlaxoSmithKline plc
  10. Dermapharm Holding
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the allergy treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global allergy treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPRE00004584
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount